Arrowstreet Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $260M | Buy |
282,798
+115,132
| +69% | +$117M | 0.14% | 137 |
|
|
2025
Q4 | $180M | Buy |
167,666
+67,263
| +67% | +$64.3M | 0.11% | 194 |
|
|
2025
Q3 | $76.6M | Buy |
+100,403
| New | +$74.7M | 0.05% | 350 |
|
|
2025
Q2 | – | Sell |
-41,407
| Closed | -$34.2M | – | 2018 |
|
|
2025
Q1 | $34.2M | Buy |
41,407
+26,559
| +179% | +$22.1M | 0.03% | 449 |
|
|
2024
Q4 | $11.5M | Sell |
14,848
-1,614,296
| -99% | -$1.34B | 0.01% | 789 |
|
|
2024
Q3 | $1.44B | Buy |
1,629,144
+20,438
| +1% | +$18.4M | 1.23% | 6 |
|
|
2024
Q2 | $1.46B | Buy |
1,608,706
+439,780
| +38% | +$352M | 1.28% | 8 |
|
|
2024
Q1 | $909M | Buy |
1,168,926
+229,255
| +24% | +$163M | 0.84% | 18 |
|
|
2023
Q4 | $548M | Sell |
939,671
-531,981
| -36% | -$311M | 0.57% | 37 |
|
|
2023
Q3 | $790M | Buy |
1,471,652
+90,169
| +7% | +$46.5M | 0.96% | 20 |
|
|
2023
Q2 | $648M | Sell |
1,381,483
-65,688
| -5% | -$27.5M | 0.79% | 22 |
|
|
2023
Q1 | $497M | Sell |
1,447,171
-486,045
| -25% | -$164M | 0.64% | 34 |
|
|
2022
Q4 | $707M | Sell |
1,933,216
-549,575
| -22% | -$195M | 0.99% | 14 |
|
|
2022
Q3 | $803M | Sell |
2,482,791
-1,086,020
| -30% | -$344M | 1.18% | 11 |
|
|
2022
Q2 | $1.16B | Buy |
3,568,811
+257,098
| +8% | +$77.2M | 1.64% | 6 |
|
|
2022
Q1 | $948M | Buy |
3,311,713
+1,172,504
| +55% | +$302M | 1.18% | 10 |
|
|
2021
Q4 | $591M | Buy |
2,139,209
+1,084,730
| +103% | +$275M | 0.72% | 20 |
|
|
2021
Q3 | $244M | Buy |
1,054,479
+988,944
| +1,509% | +$244M | 0.31% | 71 |
|
|
2021
Q2 | $15M | Sell |
65,535
-345,272
| -84% | -$69.4M | 0.02% | 706 |
|
|
2021
Q1 | $76.7M | Sell |
410,807
-431,735
| -51% | -$84.5M | 0.1% | 197 |
|
|
2020
Q4 | $142M | Sell |
842,542
-400,917
| -32% | -$59.9M | 0.2% | 90 |
|
|
2020
Q3 | $184M | Buy |
1,243,459
+343,566
| +38% | +$53.2M | 0.29% | 59 |
|
|
2020
Q2 | $148M | Buy |
899,893
+673,427
| +297% | +$103M | 0.27% | 67 |
|
|
2020
Q1 | $31.4M | Buy |
226,466
+109,069
| +93% | +$15M | 0.09% | 205 |
|
|
2019
Q4 | $15.4M | Sell |
117,397
-1,074,974
| -90% | -$125M | 0.04% | 470 |
|
|
2019
Q3 | $133M | Sell |
1,192,371
-211,300
| -15% | -$23.5M | 0.31% | 86 |
|
|
2019
Q2 | $156M | Buy |
1,403,671
+776,173
| +124% | +$91.4M | 0.35% | 70 |
|
|
2019
Q1 | $81.4M | Sell |
627,498
-1,636,116
| -72% | -$199M | 0.19% | 120 |
|
|
2018
Q4 | $262M | Sell |
2,263,614
-1,372,608
| -38% | -$153M | 0.69% | 36 |
|
|
2018
Q3 | $390M | Buy |
3,636,222
+1,227,904
| +51% | +$123M | 0.88% | 23 |
|
|
2018
Q2 | $206M | Buy |
2,408,318
+74,024
| +3% | +$6.08M | 0.5% | 54 |
|
|
2018
Q1 | $181M | Buy |
2,334,294
+1,214,407
| +108% | +$97.8M | 0.41% | 62 |
|
|
2017
Q4 | $94.6M | Buy |
1,119,887
+752,919
| +205% | +$64.1M | 0.23% | 111 |
|
|
2017
Q3 | $31.4M | Sell |
366,968
-845,856
| -70% | -$69.4M | 0.08% | 215 |
|
|
2017
Q2 | $99.8M | Buy |
1,212,824
+1,127,856
| +1,327% | +$92M | 0.3% | 94 |
|
|
2017
Q1 | $7.15M | Buy |
+84,968
| New | +$6.81M | 0.03% | 473 |
|
|
2016
Q4 | – | Sell |
-406,380
| Closed | -$32.6M | – | 2146 |
|
|
2016
Q3 | $32.6M | Sell |
406,380
-407,598
| -50% | -$32.6M | 0.11% | 190 |
|
|
2016
Q2 | $64.1M | Sell |
813,978
-868,933
| -52% | -$65.4M | 0.21% | 120 |
|
|
2016
Q1 | $121M | Buy |
1,682,911
+1,191,765
| +243% | +$90.2M | 0.51% | 33 |
|
|
2015
Q4 | $41.4M | Sell |
491,146
-201,275
| -29% | -$16.7M | 0.19% | 117 |
|
|
2015
Q3 | $57.9M | Buy |
+692,421
| New | +$58.5M | 0.27% | 81 |
|
|
2015
Q2 | – | Sell |
-17,700
| Closed | -$1.29M | – | 1237 |
|
|
2015
Q1 | $1.29M | Sell |
17,700
-378,843
| -96% | -$27M | 0.01% | 668 |
|
|
2014
Q4 | $27.4M | Sell |
396,543
-1,029,863
| -72% | -$69.5M | 0.16% | 144 |
|
|
2014
Q3 | $92.5M | Sell |
1,426,406
-403,534
| -22% | -$25.5M | 0.5% | 47 |
|
|
2014
Q2 | $114M | Buy |
1,829,940
+1,775,394
| +3,255% | +$106M | 0.58% | 38 |
|
|
2014
Q1 | $3.21M | Sell |
54,546
-1,537,004
| -97% | -$85.8M | 0.02% | 538 |
|
|
2013
Q4 | $81.2M | Sell |
1,591,550
-2,654,260
| -63% | -$133M | 0.44% | 63 |
|
|
2013
Q3 | $214M | Sell |
4,245,810
-79,115
| -2% | -$4.14M | 1.36% | 10 |
|
|
2013
Q2 | $212M | Buy |
+4,324,925
| New | +$235M | 1.58% | 8 |
|
Other funds holding LLY
VCM
VPM
Arrowstreet Capital's LLY Position: Q1 2026 in Review
Arrowstreet Capital increased its Eli Lilly (LLY) stake by 69% in Q1 2026, buying an estimated $117M and bringing the position to 282,798 shares worth $260M. The position accounts for 0.14% of the portfolio, ranked #137.
Arrowstreet Capital first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.46B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Arrowstreet Capital held 282,798 shares of Eli Lilly worth $260M as of Q1 2026.
- Arrowstreet Capital bought 115,132 Eli Lilly shares in Q1 2026, an estimated $117M.
- Eli Lilly made up 0.14% of Arrowstreet Capital's portfolio in Q1 2026, its #137 holding.
- Arrowstreet Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
- Arrowstreet Capital's Eli Lilly position peaked at $1.46B in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.